Director/PDMR Shareholding
Genus plc has announced that members of its Executive Leadership Team sold ordinary shares on September 14th and 15th, 2026, to offset tax liabilities arising from the vesting of conditional nil-cost options and share awards. Jorgen Kokke exercised 111,388 PSP options, selling 50,236 to retain 61,152 shares. Matt Culbertson, Elena Rice, and Angelle Rosata also exercised PSP and DSBP options, selling portions to cover taxes and retaining net shares. Mark Birri released and sold a portion of his PSP share awards to offset liabilities, retaining 1,187 and 912 shares respectively from two tranches. Performance conditions for PSP awards were met at 89.8%.
Select text to share a quote on X · sign in to keep highlights & notes in your GNS notes
Genus plc (LSE: GNS) announces that, further to the vesting on 13 September 2026 of conditional nil-cost options granted in 2023 under the Genus 2019 Performance Share Plan (the 'PSP'), as listed in table A below; and conditional nil-cost options granted in 2023 under the Genus Deferred Share Bonus Plan (the 'DSBP') as listed in table B below, members of the Genus Executive Leadership Team ('GELT') sold ordinary shares in Genus on 14 September 2026 on the London Stock Exchange, to offset income tax and social security liabilities due on the exercises and retained the following balances of ordinary shares:
| PDMR Name | PSP Nil-Cost Options (Table A) | DSBP (Table B) | ||||
|---|---|---|---|---|---|---|
| Exercised | Sold to offset taxes due on exercise | Retained net of tax | Exercised | Sold to offset taxes due on exercise | Retained net of tax | |
| Jorgen Kokke | 111,388 | 50,236 | 61,152 | N/A | N/A | N/A |
| Matt Culbertson | 23,183 | 6,751 | 16,432 | 1,772 | 516 | 1,256 |
| Elena Rice | 20,308 | 8,684 | 11,624 | 1,459 | 624 | 835 |
| Angelle Rosata | 18,399 | 7,371 | 11,028 | 1,237 | 496 | 741 |
Conditional nil-cost options granted under the PSP were subject to relevant performance conditions, measured over a three-year performance period which commenced on 1 July 2023 and ended on 30 June 2026. Following assessment of the performance conditions, the Remuneration Committee determined that the proportion of awards to which performance conditions applied would vest at 89.8% of the original grant and the balance of awards have lapsed.
Genus also announces that, further to the vesting on 13 September 2026 of conditional share awards granted in 2023 and 2024 under the Genus 2019 Performance Share Plan (the 'PSP'), as listed in table C below, Mark Birri, member of GELT, sold ordinary shares in Genus on 15 September 2026 on the London Stock Exchange, to offset income tax and social security liabilities due on the releases and retained the following balances of ordinary shares:
| PDMR Name | PSP Share Awards (Table C) | ||
| Released | Sold to offset taxes due on exercise | Retained net of tax | |
| Mark Birri | a. 2,246 b. 1,726 | a. 1,059 b. 814 | a. 1,187 b. 912 |
Conditional share awards were granted to Mark Birri under the PSP prior to becoming a member of GELT. These conditional share awards were not subject to company performance conditions.
The below notifications, made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, give further detail on the number of nil-cost options exercised and ordinary shares sold on 14 September 2026 and 15 September 2026.
| a. | Position/status | 1. Chief Executive Officer 2. Chief Operating Officer, Genus PIC 3. Chief Scientific Officer 4. Chief Human Resources Officer | ||||||
| b. | Initial notification /Amendment | Initial notification | ||||||
| a. | Name | Genus plc | ||||||
| b. | LEI | 54930022EOITNKSIGH56 | ||||||
| a. | Description of the Financial instrument, type of instrument Identification code | Ordinary shares of 10p each GB0002074580 | ||||||
| b. | Nature of the transaction | Exercise of nil-cost options under the PSP. | ||||||
| c. | Price(s) and volume(s) | Numbers 1 to 4 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above. Price(s) Volume(s) 1. 0p 111,388 2. 0p 23,183 3. 0p 20,308 4. 0p 18,399 | ||||||
| d. | Aggregated information · Aggregated volume · Price | NA | ||||||
| f. | Place of the transaction | Outside a trading venue. | ||||||
| a. | Description of the Financial instrument, type of instrument Identification code | Ordinary shares of 10p each GB0002074580 | ||||||
| b. | Nature of the transaction | Sale of shares arising from the exercise of nil-cost options under the PSP to offset income tax and social security liabilities due on the exercise. | ||||||
| c. | Price(s) and volume(s) | Numbers 1 to 4 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above. Price(s) Volume(s) 1. 2,150.677p 50,236 2. 2,150.677p 6,751 3. 2,128.8348p 8,684 4. 2,128.8348p 7,371 | ||||||
| d. | Aggregated information · Aggregated volume · Price | NA | ||||||
| f. | Place of the transaction | London Stock Exchange, Main Market (XLON) | ||||||
| Table B - GELT Deferred Share Bonus Plan Exercise | ||||||||
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||
| a. | Name | 1. Matt Culbertson 2. Elena Rice 3. Angelle Rosata | ||||||
| 2. | Reason for the notification | |||||||
| a. | Position/status | 1. Chief Operating Officer, Genus PIC 2. Chief Scientific Officer 3. Chief Human Resources Officer | ||||||
| b. | Initial notification /Amendment | Initial notification | ||||||
| a. | Name | Genus plc | ||||||
| b. | LEI | 54930022EOITNKSIGH56 | ||||||
| a. | Description of the Financial instrument, type of instrument Identification code | Ordinary shares of 10p each GB0002074580 | ||||||
| b. | Nature of the transaction | Exercise of nil-cost options under the DSBP. | ||||||
| c. | Price(s) and volume(s) | Numbers 1 to 3 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above. Price(s) Volume(s) 1. 0p 1,772 2. 0p 1,459 3. 0p 1,237 | ||||||
| d. | Aggregated information · Aggregated volume · Price | NA | ||||||
| f. | Place of the transaction | Outside a trading venue. | ||||||
| a. | Description of the Financial instrument, type of instrument Identification code | Ordinary shares of 10p each GB0002074580 | ||||||
| b. | Nature of the transaction | Sale of shares arising from the exercise of nil-cost options under the DSBP to offset income tax and social security liabilities due on the exercise. | ||||||
| c. | Price(s) and volume(s) | Numbers 1 to 3 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above. Price(s) Volume(s) 1. 2,150.677p 516 2. 2,128.8348p 624 3. 2,128.8348p 496 | ||||||
| d. | Aggregated information · Aggregated volume · Price | NA | ||||||
| f. | Place of the transaction | London Stock Exchange, Main Market (XLON) | ||||||
| Table C - GELT 2019 Performance Share Plan Release | ||||||||
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||
| a. | Name | Mark Birri | ||||||
| 2. | Reason for the notification | |||||||
| b. | Position/status | Chief Corporate Development Officer | ||||||
| c. | Initial notification /Amendment | Initial notification | ||||||
| d. | Name | Genus plc | ||||||
| f. | Description of the Financial instrument, type of instrument Identification code | Ordinary shares of 10p each GB0002074580 | ||||||
| g. | Nature of the transaction | Release of conditional share awards under the PSP. | ||||||
| h. | Price(s) and volume(s) |
| ||||||
| i. | Aggregated information · Aggregated volume · Price | NA | ||||||
| j. | Date of the transaction | 2026-09-15 | ||||||
| k. | Place of the transaction | Outside a trading venue. | ||||||
| a. | Description of the Financial instrument, type of instrument Identification code | Ordinary shares of 10p each GB0002074580 | ||||||
| b. | Nature of the transaction | Sale of shares arising from the release of conditional share awards under the PSP to offset income tax and social security liabilities due on the release. | ||||||
| c. | Price(s) and volume(s) |
| ||||||
| d. | Aggregated information · Aggregated volume · Price |
| ||||||
| f. | Place of the transaction | London Stock Exchange, Main Market (XLON) | ||||||
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.